Press Releases

“Dermatological Product Development for Managers” Course to Be Held April 24th-25th, 2008 at Missouri State University

Course Instructor Will Be Dr. David Osborne, Vice President of Product Development at Dow Pharmaceutical Sciences Inc. and Alum of Missouri State University.

SPRINGFIELD, Mo. & PETALUMA, Calif.--(BUSINESS WIRE)--The Department of Chemistry at Missouri State University announced today that Dr. David Osborne will teach a two-day course (April 24-25) in Springfield, Missouri titled “Dermatological Product Development for Managers.”

The course will focus on how topical product development differs from oral and parenteral dosage forms, skin structure and how to formulate products for the skin, and on the pitfalls unique to the development of semi-solid dosage forms.

Course brochure and registration forms are available online at www.dowpharmsci.com.

Dr. David Osborne has 25 issued patents and 45 publications, and was editor of the book “Topical Drug Delivery Formulations” and is Vice President of Dow Pharmaceutical Sciences, Inc., a service company in Petaluma California that specializes in topical drug product development.

About Missouri State University

The Missouri State University system enrolls 19,000 students and offers 47 graduate programs, many of which are the state’s strongest and largest of their kind. Nearly 90 percent of the University’s 700 full-time faculty members have a doctorate or the highest degree in their field.

About Dow Pharmaceutical Sciences, Inc.

Dow Pharmaceutical Sciences, Inc., www.dowpharmsci.com, a privately held company established in 1977, specializes in the development of prescription topical dermatological and ophthalmic drug products for pharmaceutical and biotechnology clients in the USA, Canada, Europe and Japan.

Contacts

Dow Pharmaceutical Sciences, Inc.
Steven R. Smith, 707-665-4672
Vice President, Marketing & Business Development
ssmith@dowpharmsci.com
or
Missouri State University
Don Hendricks, 417-836-6397
Director, University Communications
DonHendricks@Missouristate.edu

© 2008 Dow Pharmaceutical Sciences, Inc. All rights reserved.

<< Back to Press Releases